Investment Rating - The report maintains a "Buy" rating for the company with a target price of CNY 28.87, unchanged from the previous forecast [4] Core Views - The company's performance in the first three quarters of 2024 showed year-on-year growth, driven by a significant increase in the prices of second and third-generation refrigerants [4] - The company is expected to benefit from the industry's favorable cycle as a leading player in third-generation refrigerants, especially with the implementation of the 2024 quota system [4] - Despite a lower-than-expected Q3 2024 performance due to declining prices of fluoropolymers and basic chemical products, the company's refrigerant business remains strong, with prices up 29.81% year-on-year [10] - The company's strategic expansion into high-value-added fluorochemical products and its leadership in third-generation refrigerants position it well for long-term growth [10] Financial Performance - In Q3 2024, the company reported revenue of CNY 5.826 billion, a year-on-year decrease of 1.53%, and net profit of CNY 423 million, a year-on-year increase of 64.76% [10] - For the first three quarters of 2024, the company achieved revenue of CNY 17.906 billion, up 11.83% year-on-year, and net profit of CNY 1.258 billion, up 68.40% year-on-year [10] - The company's refrigerant production and sales in Q3 2024 were 141,100 tons and 85,000 tons, respectively, representing year-on-year increases of 21.73% and 10.46% [10] Industry and Market Position - The company holds a significant share of the third-generation refrigerant quota, with 37.4% of the total quota for R32, R134A, R125A, and R143A in 2025 [10] - The company's leadership in the refrigerant market is further strengthened by its ability to maintain stable prices and volumes despite policy changes [10] - The company is expanding its presence in high-value-added fluorochemical products, including the production of fourth-generation refrigerants and cooling fluids for data centers [10] Financial Forecasts - The report forecasts the company's revenue to grow from CNY 22.902 billion in 2024 to CNY 28.991 billion in 2026, with net profit expected to increase from CNY 2.033 billion in 2024 to CNY 4.238 billion in 2026 [11] - The company's EPS is projected to rise from CNY 0.75 in 2024 to CNY 1.57 in 2026 [11] - The company's ROE is expected to improve from 11.6% in 2024 to 18.6% in 2026, reflecting strong profitability and growth potential [11] Valuation and Comparables - The company's current P/E ratio is 27.87x for 2024, which is lower than the average P/E ratio of comparable companies at 27.15x [13] - The company's P/B ratio is 3.24x for 2024, indicating a reasonable valuation relative to its book value [11] - The company's EV/EBITDA ratio is projected to decline from 17.23x in 2024 to 9.32x in 2026, suggesting improving valuation metrics [12]
巨化股份2024年三季报点评:业绩同比保持增长,看好制冷剂景气周期